Our present study provides evidence that γ-OHPdG levels in cancerous tissues increase as HCC progresses in regards to tumor size, grade, stage and tumor cell proliferation status as indicated by Ki67 staining, and is significantly higher in recurrent or metastatic tumors compared to the levels in the corresponding primary HCC as well. The gene discussed is MKI67; the disease is metastatic neoplasm.